Literature DB >> 26307914

Lack of genetic association of the TGM2 gene with schizophrenia in a Chinese population.

Jiaxin Wang1, Yang Liu, Zhenqi Wang, Weili Du, Li Hui, Xinli Zhao, Xiaoxia Zhao, Xuan Zhang, Jun Wei.   

Abstract

The gene coding for transglutaminase 2 (TGM2) has been reported to be associated with schizophrenia in a White population. The present study was then designed to replicate this initial finding in a Chinese population. A total of 428 individuals with schizophrenia and 555 control participants were recruited for genetic analysis. Four single nucleotide polymorphisms present in the TGM2 gene were selected for genotyping, including rs2076380, rs7270785, rs4811528, and rs6023526, by PCR-based restriction fragment length polymorphism analysis. None of these four single nucleotide polymorphisms genotyped showed an association with schizophrenia, although these 428 cases and 555 controls had 97% power to detect a disease association in small effect size (odds ratio=1.5). The present results did not support the TGM2 association with schizophrenia. It is thus possible that the TGM2 finding may have resulted from a random error of sampling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26307914     DOI: 10.1097/YPG.0000000000000103

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  3 in total

1.  TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway.

Authors:  Ping Yang; Dong Yu; Jie Zhou; Sufei Zhuang; Tao Jiang
Journal:  Cell Cycle       Date:  2019-05-08       Impact factor: 4.534

2.  Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis.

Authors:  A R Sanders; E I Drigalenko; J Duan; W Moy; J Freda; H H H Göring; P V Gejman
Journal:  Transl Psychiatry       Date:  2017-04-18       Impact factor: 6.222

3.  The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia.

Authors:  Zahra Mohammadzadeh; Azadeh Omidkhoda; Bahram Chahardouli; Ghazaleh Hoseinzadeh; Kamran Ali Moghaddam; Seyed Asadollah Mousavi; Shahrbano Rostami
Journal:  BMC Cancer       Date:  2021-01-09       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.